Home > Resources > Whitepapers > Accelerating Antibody Development with Automated Octet Assays

Accelerating Antibody Development with Automated Octet Assays

March 11, 2019

Drug development and production is challenging, however, high throughput characterization systems can greatly accelerate discovery programs. Using a proprietary discovery and development platform technology, Avitide enables its partners to rapidly advance candidate molecules to the clinic and achieve faster and more predictable bioprocess development timelines.

Spotlight

Stem-Health Hellas S.A.

One of the most promising activities for the biotechnology industry is the field of therapeutic applications of stem cells. Stem-Health Hellas provides cord blood banking for babies born in their partner maternity centers "Mitera" and "Leto" and covers all other maternity hospitals throughout Greece. Stem Health SA is accredited by FACT-Netcord, one of only 30 cord blood banks world-wide to meet the standards of FACT (Foundation for Accreditation of Cellulary Therapy) and Netcord. Our original vision is to make Stem-Health Hellas a model company and the best stem cell bank in Greece.

OTHER WHITEPAPERS

Growing a circular economy with fungalbiotechnology

whitePaper | October 22, 2022

Fungi have the ability to transform organic materials into a rich and diverse set of useful products and provide distinct opportunities for tackling the urgent challenges before all humans

Read More

Gene, Cell, & RNA Therapy Landscape

whitePaper | January 24, 2022

The American Society of Gene & Cell Therapy (ASGCT) is the primary professional membership organization.

Read More

WHO considerations on Regulatory Convergence of Cell and Gene Therapy Products

whitePaper | December 16, 2021

Use of cells, tissues, and gene therapy products for the treatment of diseases or 72 physiological conditions has become of wide interest due to their potential to address serious 73 unmet medical needs.

Read More

Recruitment, Retention & Diversity: The Evolution of Patient Engagement in Clinical Trials

whitePaper | January 23, 2023

Recruitment, retention, and diversity are critical elements of clinical trials that, if insufficient, can jeopardize successful trial completion.

Read More

Best Practices for RIM Business Process Automation

whitePaper | December 15, 2022

Regulatory teams at life science companies are finding that effective regulatory information management (RIM) has become critical to their operations.

Read More

2022 Global Life Sciences Outlook

whitePaper | January 7, 2022

While valuations for the life sciences sector in this past year have been mixed, the underlying performance and outlook for the sector is healthy

Read More

Growing a circular economy with fungalbiotechnology

whitePaper | October 22, 2022

Fungi have the ability to transform organic materials into a rich and diverse set of useful products and provide distinct opportunities for tackling the urgent challenges before all humans

Read More

Gene, Cell, & RNA Therapy Landscape

whitePaper | January 24, 2022

The American Society of Gene & Cell Therapy (ASGCT) is the primary professional membership organization.

Read More

WHO considerations on Regulatory Convergence of Cell and Gene Therapy Products

whitePaper | December 16, 2021

Use of cells, tissues, and gene therapy products for the treatment of diseases or 72 physiological conditions has become of wide interest due to their potential to address serious 73 unmet medical needs.

Read More

Recruitment, Retention & Diversity: The Evolution of Patient Engagement in Clinical Trials

whitePaper | January 23, 2023

Recruitment, retention, and diversity are critical elements of clinical trials that, if insufficient, can jeopardize successful trial completion.

Read More

Best Practices for RIM Business Process Automation

whitePaper | December 15, 2022

Regulatory teams at life science companies are finding that
effective regulatory information management (RIM) has become critical to their operations.

Read More

2022 Global Life Sciences Outlook

whitePaper | January 7, 2022

While valuations for the life sciences sector in this past year have been mixed, the underlying performance and outlook for the sector is healthy

Read More

More Whitepapers

Spotlight

Stem-Health Hellas S.A.

One of the most promising activities for the biotechnology industry is the field of therapeutic applications of stem cells. Stem-Health Hellas provides cord blood banking for babies born in their partner maternity centers "Mitera" and "Leto" and covers all other maternity hospitals throughout Greece. Stem Health SA is accredited by FACT-Netcord, one of only 30 cord blood banks world-wide to meet the standards of FACT (Foundation for Accreditation of Cellulary Therapy) and Netcord. Our original vision is to make Stem-Health Hellas a model company and the best stem cell bank in Greece.

Events

8th International Conference on Bio-Sensing Technology

Conference

8th International Conference on Bio-Sensing Technology

Conference